MYSTAR-5-YEAR: Long-term Follow-up of Patients With Ischemic Heart Disease Treated With Cell Therapy
N/A
The MYSTAR-5-YEAR study controls the patients 5 years after treatment with ...
Status
Completed
Location
Medical University of Vienna
Start Date
2011-07
Trial ID
NCT01395212
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
PHASE2
This phase II trial tests the effect of total marrow and lymphoid irradiati...
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
PHASE1
This is a Phase I open-label, multicenter study designed to evaluate the sa...
Status
Terminated
Location
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center